G6PD Deficiency - Causes, Treatment & When to See a Doctor

What is G6PD Deficiency?

G6PD Deficiency, also known as Glucose-6-Phosphate Dehydrogenase Deficiency, is a genetic disorder that affects red blood cells. It results from a mutation in the G6PD gene, which is responsible for producing an enzyme called glucose-6-phosphate dehydrogenase. This enzyme plays a critical role in protecting red blood cells from oxidative stress. When it’s deficient, red blood cells break down prematurely, leading to hemolysis (rupture of red blood cells). This condition is inherited in an X-linked recessive pattern, meaning it primarily affects males, though females can be carriers.

According to the National Institutes of Health (NIH), G6PD Deficiency is one of the most common enzymatic disorders worldwide, particularly prevalent in regions with malaria-endemic areas. While many individuals with this deficiency live normal lives, they are at risk of severe complications when exposed to specific triggers.

Common Causes

G6PD Deficiency itself is a genetic condition, but symptoms often occur when the enzyme-deficient red blood cells encounter triggers that cause oxidative stress. Below are common triggers that can exacerbate the condition:

• Certain medications: Antibiotics like sulfonamides, antimalarial drugs (e.g., primaquine), and antimigrain (gold) treatments.
• Foods: Fava beans (favism) are a well-known trigger, as well as some shellfish and processed foods containing preservatives.
• Infections: Bacterial infections, viral illnesses, or severe stress (e.g., dehydration) can overwhelm the body’s capacity to manage oxidative stress.
• Chemicals: Exposure to certain herbicides or industrial chemicals.
• Illness: Sepsis or malaria can provoke hemolytic episodes.
• Exercise: Intense physical activity may also act as a trigger in some cases.
• Stress: Emotional or physical stress can worsen symptoms.
• High-fructose diets: Some studies suggest certain dietary components may contribute.
• Corticosteroids: Use of prednisone or other corticosteroids may increase risk.

As emphasized by the Centers for Disease Control and Prevention (CDC), identifying these triggers is key to managing G6PD Deficiency and preventing acute symptoms.

Associated Symptoms

When triggered, G6PD Deficiency can lead to a variety of symptoms caused by hemolysis. These include:

• Jaundice: Yellowing of the skin and eyes due to excess bilirubin from broken-down red blood cells.
• Dark urine: The presence of hemoglobin or bilirubin gives urine a tea-colored or cola-like appearance.
• Fatigue or weakness: Caused by reduced oxygen-carrying capacity in the blood.
• Pale or ashen skin: Results from anemia.
• Abdominal pain or cramping: Due to splenic engorgement as the spleen removes damaged red blood cells.
• Shortness of breath: From anemia or severe hemolysis.
• Headaches: A common symptom during acute episodes.
• Dark stools: A potential sign of internal bleeding or excessive iron absorption.

These symptoms can appear suddenly and may last for days. The Mayo Clinic notes that severe cases can lead to complications like aplastic crises, where the bone marrow temporarily stops producing red blood cells.

When to See a Doctor

Individuals with G6PD Deficiency should consult a healthcare provider promptly if they experience any of the following signs, especially during a known trigger exposure:

• Severe jaundice or dark urine
• Unusual fatigue or dizziness
• Pallor or cold extremities
• Abdominal pain worsening over time
• Fever or signs of infection

Even if symptoms seem mild, seeking medical advice is crucial. Early intervention can prevent complications like hypoxia (low oxygen levels) or hemolytic anemia.

Diagnosis

Diagnosing G6PD Deficiency involves blood tests to measure enzyme activity in red blood cells. Common methods include:

• Ozonolysis Test: A rapid, visual test where red blood cells are exposed to oxygen. Deficient cells swell or discolor, indicating reduced G6PD activity.
• Methylene Blue Test: Involves adding methylene blue to blood, which causes Heinz bodies (abnormal red blood cells) in deficient individuals.
• Enzyme Assay:
• Genetic Testing: Identifies mutations in the G6PD gene for confirmatory diagnosis.

Newborn screening programs in some countries, as recommended by the World Health Organization (WHO), can detect G6PD Deficiency early. Diagnosis is typically confirmed through a combination of clinical evaluation and laboratory tests.

Treatment Options

While there’s no cure for G6PD Deficiency, treatment focuses on managing symptoms during acute episodes and preventing further hemolysis. Options include:

• Avoiding Triggers: Eliminating exposure to known culprits like fava beans or specific medications (advice from CDC).
• Hydration: Staying well-hydrated helps maintain red blood cell function.
• Medications:
  • Acetaminophen (Tylenol) for pain or fever (avoid ibuprofen or other NSAIDs, which are harmful).
  • Intravenous immunoglobulin (IVIG) in severe cases to modulate the immune response.
  • Corticosteroids may be used, though evidence of effectiveness is limited.
• Blood Transfusion: Reserved for life-threatening anemia (NIH).

According to the Cleveland Clinic, home remedies like rest and avoiding stressors are recommended during mild episodes. However, patients should never self-medicate without a doctor’s guidance.

Prevention Tips

Preventing severe episodes involves proactive measures:

• Dietary Adjustments: Avoid fava beans, onions, garlic, and foods high in nitrate preservatives.
• Medication Review: Consult a doctor before taking drugs known to trigger hemolysis, such as primaquine or dapsone.
• Emergency Kit: Carry a medical bracelet or ID card indicating G6PD Deficiency.
• Education: Learn to recognize early symptoms for prompt action.
• Safe Alternatives: Use G6PD-safe antibiotics or antimalarials (check with healthcare providers).

Prevention is emphasized by the World Health Organization (WHO), particularly in regions with high disease prevalence.

Emergency Warning Signs

Emergency care is critical to prevent life-threatening complications like shock or coma during acute hemolytic crises.